News & Press Releases

Comments from Member Steven Shparber were featured in Corporate Counsel regarding the Department of Energy’s proposal to federally standardize how large electricity customers, like AI data centers, connect to the power grid. The proposal marks a major shift that could transform how these energy-intensive facilities come online and interact with the grid, creating both new challenges and opportunities across the industry.

Mintz advised Andromeda Robotics on its AU$23 million Series A capital raise, led by San Francisco’s Forerunner Ventures.

Steven Shparber, Mintz Member, was quoted in a recent Utility Dive article analyzing the Federal Energy Regulatory Commission’s (FERC) rejection of Tri-State Generation and Transmission Association’s proposed large load tariff. The decision, which found that Tri-State’s proposal intruded on retail rate regulation—an area reserved for state jurisdiction—comes as FERC begins considering a U.S. Department of Energy proposal to streamline interconnections for data centers and other large loads.

Steven Shparber, Mintz Member, was quoted in a recent Law360 article covering U.S. Department of Energy Secretary Chris Wright’s proposal urging the Federal Energy Regulatory Commission (FERC) to establish standardized procedures for interconnecting data centers and other large loads to the grid. The proposal argues that such interconnections fall squarely within FERC’s jurisdiction and are critical to supporting domestic manufacturing and AI innovation.

Business Law Today highlighted comments from Privacy & Cybersecurity Practice Co-chair Scott Lashway, who spoke on a panel at the American Bar Association Business Law Fall Meeting in September. Discussing the role of intellectual property in business transactions, the panel addressed important considerations for the various types of IP, distinguishing the less concrete “lowercase ip” from the more formalized “uppercase IP.”

Mintz advised the underwriters in connection with a $603 million public offering by Praxis Precision Medicines of 3,527,072 shares of common stock (which includes 501,592 shares of common stock issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock) at a public offering price of $157.00 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 318,470 shares of common stock at the public offering price per share less the $0.0001 per share exercise price of each pre-funded warrant. The aggregate gross proceeds to Praxis Precision Medicines from this offering were approximately $603 million before deducting underwriting discounts and commissions and other offering expenses.